Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. Gliclazide is the research of SERVIER- A French Multinational. In India original Gliclazide is marketed in original Brand name as Diamicron XR 60 by SERVIER subsidiary SERDIA Pharmaceuticals while other companies promote copies are Glizid Glyloc and Reclide in India . In the Philippines Servier markets it as Diamicron MR like in most countries across the world.
This page contains content from the copyrighted Wikipedia article "Gliclazide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
